Treatment persistence and adherence and their consequences on patient outcomes of generic versus brand-name statins routinely used to treat high cholesterol levels in Spain: a retrospective cost-consequences analysis
| dc.contributor.author | Sicras Mainar, Antoni | |
| dc.contributor.author | Sánchez-Álvarez, Luis | |
| dc.contributor.author | Navarro-Artieda, Ruth | |
| dc.contributor.author | Darbà, Josep | |
| dc.date.accessioned | 2019-04-03T11:42:45Z | |
| dc.date.available | 2019-04-03T11:42:45Z | |
| dc.date.issued | 2018-12 | |
| dc.date.updated | 2019-04-03T11:42:45Z | |
| dc.description.abstract | High blood lipoprotein concentrations are one of the major risk factors for cardiovascular diseases. Drug therapy is the base of treatment; statins in particular. Both brand-name and generic presentations are available for statin therapy of high cholesterol levels. Factors that may influence their use in routine medical practice include, among others, patient persistence and adherence to treatment as prescribed by physicians. The aim of this retrospective analysis was to provide real-world evidence of treatment persistence and adherence and their consequences on economic and patient outcomes of generic versus brand-name statins routinely used to treat high cholesterol levels in Spain. | |
| dc.format.extent | 16 p. | |
| dc.format.mimetype | application/pdf | |
| dc.identifier.idgrec | 686011 | |
| dc.identifier.issn | 1476-511X | |
| dc.identifier.pmid | 30522491 | |
| dc.identifier.uri | https://hdl.handle.net/2445/131252 | |
| dc.language.iso | eng | |
| dc.publisher | BioMed Central | |
| dc.relation.isformatof | Reproducció del document publicat a: https://doi.org/10.1186/s12944-018-0918-y | |
| dc.relation.ispartof | Lipids In Health And Disease, 2018, vol. 17, num. 277, p. 01-16 | |
| dc.relation.uri | https://doi.org/10.1186/s12944-018-0918-y | |
| dc.rights | cc-by (c) Sicras Mainar, Antoni et al., 2018 | |
| dc.rights.accessRights | info:eu-repo/semantics/openAccess | |
| dc.rights.uri | http://creativecommons.org/licenses/by/3.0/es | |
| dc.source | Articles publicats en revistes (Economia) | |
| dc.subject.classification | Sistemes d'administració de medicaments | |
| dc.subject.classification | Colesterol | |
| dc.subject.classification | Prescripció de medicaments | |
| dc.subject.classification | Anàlisi econòmica | |
| dc.subject.classification | Política sanitària | |
| dc.subject.classification | Anàlisi cost-benefici | |
| dc.subject.other | Drug delivery devices | |
| dc.subject.other | Cholesterol | |
| dc.subject.other | Drug prescribing | |
| dc.subject.other | Economic analysis | |
| dc.subject.other | Medical policy | |
| dc.subject.other | Cost effectiveness | |
| dc.title | Treatment persistence and adherence and their consequences on patient outcomes of generic versus brand-name statins routinely used to treat high cholesterol levels in Spain: a retrospective cost-consequences analysis | |
| dc.type | info:eu-repo/semantics/article | |
| dc.type | info:eu-repo/semantics/publishedVersion |
Fitxers
Paquet original
1 - 1 de 1